Atlas Trials

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

Clinical trial NCT05705505 · UNKNOWN

Trial details

NCT number
NCT05705505
Sponsor
Traws Pharma, Inc.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Endometrioid Endometrial Cancer
Start date
2023-03-29
Primary completion
2026-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.